城市医院中及时治疗重度高血压与严重孕产妇发病率风险的关系
本研究在城市医院2016至2018年3723例分娩中分析妊娠期高血压疾病、重度高血压及治疗及时性对严重孕产妇发病率的影响。结果显示重度高血压未及时治疗者风险最高(调整RR 5.38),及时治疗者风险较低(调整RR 3.81),但仍高于无重度高血压者。
要点
- 妊娠期高血压疾病无重度高血压者严重孕产妇发病率124.4/1000,高于无高血压疾病者的52.0/1000。
- 重度高血压及时治疗者严重孕产妇发病率233.0/1000,调整RR 3.81(95%CI 2.45-5.92)。
- 重度高血压延迟治疗者严重孕产妇发病率305.6/1000,调整RR 5.38(95%CI 3.75-7.73)。
核心结论
- 妊娠期高血压疾病患者严重孕产妇发病风险升高,发生重度高血压进一步增加该风险;及时抗高血压治疗与重度高血压患者较低的严重孕产妇发病风险相关。
研究设计与样本
- 2016至2018年单家城市医院的群体队列研究,纳入3723例分娩,包括有和无妊娠期高血压疾病者。
- 在妊娠期高血压疾病患者中识别持续性重度高血压(血压≥160/105 mm Hg持续≥15分钟),并分为及时治疗(60分钟内)或延迟治疗。
- 严重孕产妇发病率采用美国疾病控制与预防中心开发的复合指标识别。
- 使用多因素稳健泊松回归分析,调整人口学和临床特征。
主要发现
- 3723例分娩住院中,32.3%(1204/3723)为妊娠期高血压疾病无重度高血压,5.7%(211/3723)为妊娠期高血压疾病伴重度高血压。
- 重度高血压患者中48.8%(103/211)接受了及时治疗。
- 与无妊娠期高血压疾病分娩相比,妊娠期高血压疾病无重度高血压者严重孕产妇发病率升高(124.4/1000 vs 52.0/1000;调整RR 1.84;95%CI 1.41-2.40)。
- 重度高血压及时治疗者严重孕产妇发病率为233.0/1000(调整RR 3.81;95%CI 2.45-5.92)。
- 重度高血压延迟治疗者严重孕产妇发病率为305.6/1000(调整RR 5.38;95%CI 3.75-7.73)。
关键数值与推荐
- 持续性重度高血压定义为血压≥160/105 mm Hg持续≥15分钟。
- 及时治疗定义为60分钟内给予抗高血压治疗。
临床怎么用
- 作者认为这些发现强调了对提供者进行教育和质量改进以加快重度高血压治疗的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertensive disorders of pregnancy have been identified as a leading contributor to severe maternal morbidity and mortality. Pregnant persons with hypertensive disorders who develop severe hypertension at delivery admission have been shown to experience higher rates of severe maternal morbidity relative to those without severe hypertension. Current guidelines recommend prompt treatment of severe hypertension given known associated maternal and fetal risks; however, only 1 previous study has described an association between timeliness of antihypertensive therapy and risk of severe maternal morbidity. OBJECTIVE: This study aimed to characterize how development of severe intrapartum hypertension and its timely treatment affect the risk of severe maternal morbidity. STUDY DESIGN: We conducted a population cohort study of deliveries with and without hypertensive disorders of pregnancy at a single urban hospital between 2016 and 2018. Among deliveries of persons with hypertensive disorders of pregnancy, we identified those with persistent severe hypertension (defined as blood pressure ≥160/105 mm Hg sustained over ≥15 minutes) and further classified individuals with severe hypertension as having received timely (within 60 minutes) or delayed treatment. Severe maternal morbidity was identified using a composite measure developed by the Centers for Disease Control and Prevention. We calculated overall and indicator-specific rates of severe maternal morbidity for 4 categories of deliveries: without hypertensive disorder of pregnancy, with hypertensive disorder of pregnancy without severe hypertension, with severe hypertension and timely treatment, and with severe hypertension and delayed treatment. We assessed the association between hypertensive disorder of pregnancy, severe hypertension, timeliness of treatment, and severe maternal morbidity using multivariable robust Poisson regression, adjusting for demographic and clinical characteristics. RESULTS: Of 3723 delivery hospitalizations within the study time frame, 32.3% (1204/3723) were complicated by presence of a hypertensive disorder without severe hypertension and 5.7% (211/3723) by presence of a hypertensive disorder with severe hypertension. Among those with severe hypertension, 48.8% (103/211) received timely treatment. Compared with deliveries not complicated by a hypertensive disorder, severe maternal morbidity risk was increased for hypertensive disorder of pregnancy without severe hypertension (124.4/1000 vs 52.0/1000; adjusted risk ratio, 1.84; 95% confidence interval, 1.41-2.40), severe hypertension with timely treatment (233.0/1000; adjusted risk ratio, 3.81; 95% confidence interval, 2.45-5.92), and severe hypertension with delayed treatment (305.6/1000; adjusted risk ratio, 5.38; 95% confidence interval, 3.75-7.73). CONCLUSION: Patients with hypertensive disorders of pregnancy are at an elevated risk of severe maternal morbidity, and development of severe hypertension further increases this risk. Timely antihypertensive treatment is associated with lower risk of severe maternal morbidity among those with severe hypertension. These findings emphasize the importance of provider education and quality improvement efforts aimed at expediting treatment of severe hypertension.
引用
- Vuncannon DM, Platner MH, Boulet SL, et al. Timely treatment of severe hypertension and risk of severe maternal morbidity at an urban hospital. Am J Obstet Gynecol MFM. 2022. PMID: 36379440. doi:10.1016/j.ajogmf.2022.100809
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。